Innovita Biological Technology Co., Ltd. (SHA:688253)

China · Delayed Price · Currency is CNY

35.38

+0.15 (0.43%)

At close: Feb 12, 2026

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Respiratory Series	606.69M
Other Reagent Series	10.36M
Other Reagent Series Growth	7.42%
Eugenics Series	4.17M
Eugenics Series Growth	0.80%
Point-of-care Testing Diagnostic Equipment	159.29K
Point-of-care Testing Diagnostic Equipment Growth	-70.00%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
China	605.76M
China Growth	30.28%
Overseas (including Hong Kong, Macau and Taiwan)	15.63M
Overseas (including Hong Kong, Macau and Taiwan) Growth	19.69%